The estimated Net Worth of Karen A. Foster is at least 4.95 百万$ dollars as of 29 May 2024. Ms Foster owns over 408 units of Biolife Solutions Inc stock worth over 3,667,985$ and over the last 9 years she sold BLFS stock worth over 940,052$. In addition, she makes 345,731$ as Chief Quality Officer at Biolife Solutions Inc.
Ms has made over 61 trades of the Biolife Solutions Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she sold 408 units of BLFS stock worth 8,886$ on 29 May 2024.
The largest trade she's ever made was exercising 38,836 units of Biolife Solutions Inc stock on 12 April 2022 worth over 900,607$. On average, Ms trades about 3,351 units every 19 days since 2016. As of 29 May 2024 she still owns at least 158,171 units of Biolife Solutions Inc stock.
You can see the complete history of Ms Foster stock trades at the bottom of the page.
Karen Foster is the Chief Quality Officer at Biolife Solutions Inc.
As the Chief Quality Officer of Biolife Solutions Inc, the total compensation of Ms Foster at Biolife Solutions Inc is 345,731$. There are 6 executives at Biolife Solutions Inc getting paid more, with Michael Rice having the highest compensation of 2,241,770$.
Ms Foster is 61, she's been the Chief Quality Officer of Biolife Solutions Inc since . There are no older and 14 younger executives at Biolife Solutions Inc.
Karen's mailing address filed with the SEC is 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL, WA, 98021.
Over the last 22 years, insiders at Biolife Solutions Inc have traded over 156,215,880$ worth of Biolife Solutions Inc stock and bought 12,236,637 units worth 91,960,074$ . The most active insiders traders include Partners Master Fund, L.P.C...、Thomas Girschweiler、Walter Villiger. On average, Biolife Solutions Inc executives and independent directors trade stock every 13 days with the average trade being worth of 1,018,157$. The most recent stock trade was executed by Sarah Aebersold on 1 July 2024, trading 3,000 units of BLFS stock currently worth 63,090$.
bothell, wa-based biolife solutions, inc. (nasdaq: blfs), is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.
Biolife Solutions Inc executives and other stock owners filed with the SEC include: